Donald Abrams of the University of California San Francisco examines the state of the evidence surrounding the medical use of Cannabis, or marijuana. The Controlled Substances Act of the 1970 classified marijuana as a Schedule I drug, which designates it as having no medical use. This classification, according to Abrams, hampered research efforts for the next 30 years. Still, various indirect studies and studies from outside the U.S. have been able to associate the use of cannabinoids to immune function, cell proliferation, pain, and other effects. According to Abrams, researchers believe Cannabidiol (CBD) and other compounds have anti-inflammatory, antioxidant, anti-tumor effects. Abrams argues that medical marijuana ought to be available for study and use.
YOU MIGHT ALSO LIKE
"When I need to get up to speed on some new issue, I go to HealthPolicy.tv."
— Ben C., Baltimore, MD